Company / Working Capital per Share
Summit Therapeutics Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.87
FY2025
5-year range
$0.21 / $6.30
FY2021-FY2025
Trend
+59.0%
vs FY2024
Sector context
#186 of 210
Health Care
What the data says
Summit Therapeutics Inc.'s working capital per share of $0.87 is lower than 89% of companies in the Health Care sector (FY2025). Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $0.87.
Based on SEC 10-K filings.
0.87 in FY2025 with a 5-year CAGR of -3.0%.
Improved from $0.80 to $0.87 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -48.4%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 210This company $0.87 Sector average $146.86
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 59.0% year-over-year.
- Ranks #186 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.87 | +59.0% |
| FY2024 | $0.54 | -32.1% |
| FY2023 | $0.80 | -87.3% |
| FY2022 | $6.30 | +2855.5% |
| FY2021 | $0.21 | -78.9% |
| FY2020 | $1.01 | -49.7% |
| FY2019 | $2.01 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026